| Application no. and date | 01927674.0 (espacenet) (Federated) (European Patent Register), 20010216 | | Patent/reg. no. and date | DK/EP 1255564, 20031112 | | Publication date | 20021113 | | Priority no. and date | GB 0003932, 20000218 | | EP pub. no. and date |
EP 1255564 20021113 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4002 Basel, CH | | Applicant ref. no. | 116849 | | Inventor | RYDER, Neil, Stewart, Donizettiweg 5
A-1220 Wien, AT,
MAYER, Friedrich, Karl, Im Ziegelgarten 9
CH-4104 Oberwil, CH | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/00, A61P 37/02, A61K 45/06 | | Title | Farmaceutisk sammensætning omfattende squalenepoxydasehæmmer og makrolid immunomodulator | | Int. application no. | EP2001001744 | | Int. publication no. | WO2001060345 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
